Related Experiment Video
Updated: Sep 17, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
How Artificial Intelligence Assists in Overcoming Drug Resistance?
Ferdinand Ndikuryayo1, Xue-Yan Gong1, Ge-Fei Hao1
1State Key Laboratory of Green Pesticide, Center for R&D of Fine Chemicals of Guizhou University, Guiyang, Guizhou, China.
Abstract:
The increasing prevalence of drug resistance (DR) and pesticide resistance poses a significant threat to public health, necessitating the development of innovative strategies to discover more effective drugs and pesticides. In this context, artificial intelligence (AI) has emerged as a promising solution. This review examines the roles of AI in tackling DR. An analysis of current literature reveals that AI can enhance the drug discovery process, facilitating the faster creation of effective and safer medications. Furthermore, AI is crucial in predicting and elucidating the mechanisms of DR and pesticide resistance. By offering decision support to healthcare providers, AI-driven precision medicine paves the way for personalized treatment options. Moreover, AI aids in identifying synergistic drug combinations essential for combating DR. Lessons from the recent use of AI in addressing DR demonstrate the potential of this versatile tool to offer solutions required for controlling infections and cancers in the era of DR. However, despite the advancements achieved, challenges such as data accessibility and ethical issues remain. This highlights the need for interdisciplinary collaboration and ethical consideration. Finally, we provide an outlook on future actions required to successfully implement AI-powered technologies in drug and pesticide discovery.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Related Concept Videos
Treatment Resistant Cancers
Development of Antibiotic Resistance
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...